.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Experts Share Insights on NCCN Guidelines for Metastatic TNBC

As part of its Speaking Out video series, CURE spoke with Rebecca Moroose, MD, from Orlando Health Cancer Institute, and Virginia G. Kaklamani, MD, from UT Health San Antonio, about the National Comprehensive Cancer Network guidelines and what they mean for patients.

EP. 1: The Impact of the NCCN Guidelines on Metastatic TNBC Treatment

December 17th 2021

CURE discusses the National Comprehensive Cancer Network guidelines and what they mean for patients with metastatic triple-negative breast cancer.

EP. 2: NCCN Guidelines: How to Shared Decisions in Metastatic TNBC Treatment

December 17th 2021

As part of its CURE Speaking Out video series, CURE spoke with Rebecca Moroose, MD, from Orlando Health Cancer Institute, and Virginia G. Kaklamani, MD, from UT Health San Antonio, about shared-decision making with the NCCN guidelines on metastatic triple-negative breast cancer.